Integrative therapeutic effects of cannabinoids in breast cancer: scoping review
DOI:
https://doi.org/10.33448/rsd-v11i4.27212Keywords:
Therapeutic uses of cannabis; Therapy; Breast cancer; Breast neoplasms.Abstract
This study aimed to map the scope of scientific evidence on the therapeutic effects of cannabinoids on breast cancer. Methodological study to review the scientific literature in the bases: Scopus, PubMed and MEDline, being accessed through the CAPES/MEC Journal Portal and in the bases: Science Direct, Cochrane and Virtual Health Library. After testing and retesting using the operator Boolean connective AND, the following descriptors were applied to the databases: (therapeutic uses cannabis) AND (therapy) AND (breast cancer or breast neoplasms). The results found showed six studies, only one of the quantitative type and five of literature review that presented the integrative therapeutic use of cannabinoids and their benefits for the relief of symptoms. It was concluded that there is a lack of scientific evidence on the relief of symptoms and ways of using integrative cannabinoid therapy in breast cancer.
References
American Cancer Society. What is breast cancer?. (2019). Atlanta: American Cancer Society.
Areesantichai, C., Perngparn, U., & Pilley, C.(2020). Current cannabis-related situation in the Asia-Pacific region, Current Opinion in Psychiatry. 33(4), p 352-359 doi: 10.1097/YCO.0000000000000616.
Arksey H, & O’malley L. (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol, 8(1):19-32.
Blasco-Benito, S., Seijo-Vila, M., Caro-Villalobos, M., Tundidor, I., Andradas, C., García-Taboada, E. & Sánchez, C. (2018). Appraising the "entourage effect": antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochemical pharmacology, 157, 285–293.
Bray, F, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, Hoboken, 68(6): 394-424.
Brasil. Supremo Tribunal Federal. (2013). Recurso extraordinário com agravo: ARE. 784136.
Center for Evidence-based Medicine. (2009). Oxford Center for Evidence-based Medicine: levels of evidence.
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES. (2022). Periodicos CAPES. Avalilable from: https://www-periodicos-capes-gov-br.ez76.periodicos.capes.gov.br/index.php/buscador-primo.html.
Cohen, M. A, Quintner, J. B., & Van Rysewyk, S.C. (2018). Reconsiderando a definição de dor da Associação Internacional para o Estudo da Dor, Relatórios PAIN: março/abril, 3(2), e634. 10.1097/PR9.0000000000000634.
Darkovska-Serafimovska, M. et al. (2018). Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. Journal of pain research, 11, 837–842. https://doi.org/10.2147/JPR.S160556. Avalilable from: https://pubmed.ncbi.nlm.nih.gov/29719417.
Delgado, D., & Kelmis Ávila, B. (2020). Efectos paliativos del cannabinoides en el Cáncer de mama estudio del caso a partir de una revisión de la literatura. Anuario de Investigación, 56.
Farias Moreira, E. M., & Sousa, M. N. A. (2021). Uso terapêutico da cannabis sativa para o tratamento de doenças.
Instituto Nacional de Câncer José Alencar Gomes da Silva.(2021). Incidência nacional estimada para o câncer de mama e tipos oncológicos mamários mais frequentes.https://www.inca.gov.br/controle-do-cancer-de-mama/conceito-e-magnitude.
Instituto Nacional de Câncer José Alencar Gomes da Silva.(2021). Detecção precoce, diagnóstico e tratamento do cancer de mama. https://www.inca.gov.br/controle-do-cancer-de-mama/
Joanna Briggs Institute.(2022). Evidence Implementation Training Program. https://jbi.global/education/evidence-implementation-training
Kis, B., Ifrim, F. C., Buda, V., Avram, S., Pavel, I. Z., Antal, D., & Danciu, C. (2019). Cannabidiol-from plant to human body: a promising bioactive molecule with multi-target effects in cancer. International journal of molecular sciences, 20(23), 5905.
Kisková, T., Mungenast, F., Suváková, M., Jäger, W., & Thalhammer, T. (2019). Future aspects for cannabinoids in breast cancer therapy. International Journal of Molecular Sciences, 20(7), 1673.
Karlberg, J. P. E. Revisão de Estudos Clínicos: Um Guia para o Comitê de Ética (2010) Karlberg, Johan Petter Einar. Hong Kong, China. 153 p. ISBN 978-988-19041-1-9.
Kitchen, C., Kabba, J. A., & Fang, Y. Status and Impacts of Recreational and Medicinal Cannabis Policies in Africa: A Systematic Review and Thematic Analysis of Published and "Gray" Literature. Cannabis Cannabinoid Res. 2022 Jan 5. doi: 10.1089/can.2021.0110.
Lal, S., Shekher, A., Puneet, Narula, A.S., Abrahamse, H., & Gupta, S. C. (2021). Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities. Pharmacological research, 163, 105302.
Lee, C. X., Werner, E., & Falasca, M. (2021). Molecular mechanism of autophagy and its regulation by cannabinoids in cancer. Cancers, 13(6), 1-27.
Levac D, Colquhoun H, & O’brien K.K. (2010). Scoping studies: advancing the methodology. Implement Sci. 5(69), 1-9.
Lima, A. A. de, Alexandre, U. C., & Santos, J. S. (2021). The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review. Research Society and Development, 10(12), e46101219829.
Lima, et al. (2021). Avaliação da dor em pacientes com diagnóstico de câncer de colo do útero em Sergipe. Revista Eletrônica Acervo Saúde, 13(3). Disponivel em: https://acervomais.com.br/index.php/saude/article/view/6573/4295.
Lopes, J. V., Bergerot, C. D., Barbosa, L. R., Calux, N. M. D. C. T., Elias, S., Ashing, K. T., & Domenico, E. B. L. D. (2018). Impacto do câncer de mama e qualidade de vida de mulheres sobreviventes. Revista Brasileira de Enfermagem, 71(6), 2916-2921.
Maulaz, C. M., Valentini, B. B., da Silva, A. M. M., & Papaleo, R. M. (2019). Estudo comparativo do desempenho de imagens por ressonância magnética, mamografia e ecografia na avaliação de lesões mamárias benignas e malignas. Revista Brasileita de Física Médica (Impresso).
Martins, I. O. (2021). A desburocratização do uso e plantio da cannabis medicinal no Brasil.
Menezes, S. S. C.,Corrêa, C. G., Silva, R. C. G.,Cruz, D. A. M. L. (2015). Raciocínio clínico no ensino de graduação em enfermagem: revisão de escopo. Rev. Esc. Enferm. Usp., 49(6), 1037-44.
Millán-Guerrero, R. O. & Isais-Millán, S. (2019). Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias. Gaceta Médica de México, 155(5), 508-512.
Moher D., Liberati A., Tetzlaff J., & Altman D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol, 62(10), p.1006-12. PMid:19631508.
Mokoena, D. R., P George, B., & Abrahamse, H. (2019). Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy. International journal of molecular sciences, 20(19), 4771.
Mohammed, K., Ibrahim, A. M., & Ginawi, Awdah, A. H. (2013). Cannabis sativa: An ancient wild edible plant of India. Emir. J. Alimentos Agrícolas. 2013. 25(10): 736-745. 10.9755/ejfa.v25i10.16400. http://www.ejfa.info.
Ministério da Saúde. (2021). Anvisa aprova dois novos produtos à base de Cannabis.
Moreira, E. A., & Ramos, R. (2021). Potencial antineoplásico dos fitocanabinóides. Revista Multidisciplinar em Saúde, 2(4), 137-137.
Nammi, S., Doh, E. J., Lee, G.,Yun, YJ., Kang, LW., Kim, E. S., Lee, M. Y., Oh, SE. (2019). DNA Markers to Discriminate Cannabis sativa L. ‘Cheungsam’ with Low Tetrahydrocannabinol (THC). Content from Other South Korea Cultivars Based on the Nucleotide Sequences of Tetrahydrocannabinolic Acid Synthase and Putative 3-Ketoacyl-CoA Synthase Genes. 10.1155/2019/8121796, https://doi.org/10.1155/2019/8121796796.
Noori, A. et al. W. (2021). Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ open, 11(7), 47717. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319983. https://doi.org/10.1136/bmjopen-2020-047717.
Nigro, E., Formato, M., Crescente, G., & Daniele, A. (2021). Cancer initiation, progression and resistance: are phytocannabinoids from cannabis sativa l. promising compounds? Molecules, 26(9), p. 2668.
Nunes, V. L. S., Resende, W. A., Cabral, G. V. S., Oliveira, F. D. S. R., e Santos Silva, R. R. (2020). A importância da educação em saúde como forma de prevenção ao câncer de mama: um relato de experiência em uma unidade básica de saúde de Palmas/TO. Revista Extensão, 4(2), 108-114.
Oliveira, E. H. A., Sorgato, J. P. A., Silva, R. C., Martins, P. K. da S., Uchôa, S. B. B., & Tonholo, J. (2018). Mapeamento Tecnológico do Canabidiol (CBD) para Finalidades Farmacêuticas no Brasil. Cadernos de Prospecção, 11(3), 900.
Oliveira, A. L. R., Michelini, F. S., Spada, F. C., Pires, K. G., de Oliveira Costa, L., de Figueiredo, S. B. C., & Lemos, A. (2020). Fatores de risco e prevenção do câncer de mama. Cadernos da Medicina-UNIFESO, 2(3).
Oliveira, M. E. C., Gomes, K. A. L., Nóbrega, W. F. S., da Silva, G. C. B., Barbosa, D. V., Franklin, R. G., & dos Santos, R. D. (2021). Cannabis e Câncer de mama: Evidências com células in vitro. Research, Society and Development, 10(10), e09101018387-e09101018387.
Oxford Centre for Evidence-based Medicine: levels of evidence (2009) http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009.
Peters, M. D. J., Godfrey, C. M., McInerney, P., Soares, C. B., Khalil, H., & Parker, D. (2015). The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews. Adelaide: The Joanna Briggs Institute. http://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf
Peters, M. D. J., Marnie, C., Tricco, A.C., Pollock, D., Munn, Z., Alexander, L., Mcinerney, P., Godfrey, C.M. and Khalil, H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI evidence synthesis [online], 18(10), p. 2119-2126. Available from: https://doi.org/10.11124/JBIES-20-00167.
Pollock, D., Tricco, A. C., Peters, M. D. J , McInerney, P. A., Khalil, Ha., Godfrey, C. M., Alexander, L. A., & Munn, Z. (2015). Methodological quality, guidance, and tools in scoping reviews: a scoping review protocol, Síntese de Evidências JBI.
Pollock D., Davies E. L., Peters M. D. J., Tricco, A. C., Alexander, L., McInerney, P., Godfrey, C. M., Khalil, H. & Munn, Z. (2021). Undertaking a scoping review: A practical guide for nursing and midwifery students, clinicians, researchers, and academics. J Adv Nurs, 77(4), p.2102-2113. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jan.14743.
Procópio, A. M. M., Nascimento, B. M., Hoyashi, C. M. T., Canavez, M. F., Pereira, R. M. & Oliveira, V. C. S. (2022). Câncer de mama: conhecimento de mulheres sobre fatores de risco e rastreamento. Research, Society and Development, 11(3), e38311326438, http://dx.doi.org/10.33448/rsd-v11i3.26438
Rahman, S., Archana, A., Dutta, D., Kumar, V., Kim, J., Jan, A. T., & Minakshi, R. (2019). The Onus Of Cannabinoids In Interrupting The Molecular Odyssey Of Breast cancer: A critical perspective on UPRER and beyond. Saudi Pharmaceutical Journal, 27(3), 437-445.
Resolução RE Nº 4.673, de 15 de dezembro de 2021. (2021). Diário Oficial Da União: Publicado Em: 17/12/2021. 237(1), p. 155 Ministério Da Saúde/Agência Nacional De Vigilância Sanitária/2ª Diretoria/Gerência-Geral de Medicamentos e Produtos Biológicos.
Rojas-Jara, C., Polanco-Carrasco, R., Cisterna, R., Hernández, V., Miranda, F., Moreno, A. Alarcón, L. (2019). Uso medicinal da cannabis: uma revisão das evidências. Ter Psicol,37(2). http://dx.doi.org/10.4067/S0718-48082019000200166.
Russo, E. B., & Marcu, J. (2017). Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads. Advances in Pharmacology, 80. Elsevier Inc. https://doi.org/10.1016/bs.apha.2017.03.004
Schoeman, R., Beukes, N., & Frost, C. (2020). Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells. Molecules (Basel, Switzerland), 25(20), 4682.
Seltzer, E. S., Watters, A. K., MacKenzie, D., Jr, Granat, L. M., & Zhang, D. (2020). Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers, 12(11), 3203.
Silva, G. C. et al. (2019). Cannabis and Cannabinoids for Medical Use. Port. Farmacoter, 11(1), 21-31. http://revista.farmacoterapia.pt/index.php/rpf/article/view/211.
Soares, J. C. N., Souza, A. M. M., Souza, S. M. A., & Rolim, I. L. T. P. (2019). Aleitamento Materno na Prevenção do Câncer de Mama: uma revisão integrativa da literatura. Revista Uningá, 56(6), 13-22.
Urits, I. et al. (2019). Uma atualização dos atuais produtos farmacêuticos à base de cannabis na medicina da dor. Dor e terapia, 8(1), p. 41–51. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514017. DOI: https://doi.org/10.1007/s40122-019-0114-4
Tricco A.C, Lillie E, Zarin W, O’Brien K. K, Colquhoun H, Levac D., et al. (2018) Prisma: extension for scoping reviews (Prisma-ScR): checklist and explanation. Ann Intern Med. 169(7):467-73.
Vieira, L. S., Marques, A. E. F., Sousa, V.A. (2020). O uso de Cannabis sativa para fins terapêuticos no Brasil: uma revisão de literatura. Scientia Naturalis, 2(2), 901-919. https://periodicos.ufac.br/index.php/SciNat/article/view/3737>.
World Health Organization.(2020). International agency for research on cancer cancer today. Brasil. Globocan. https://gco.iarc.fr/today/data/factsheets/populations/76-brazil-fact-sheets.pdf.
World Health Organization. (2017). http://www.who.int/eportuguese/countries/bra/pt/>.
Zou, S., & Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International journal of molecular sciences, 19(3). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877694.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ana Claudia de Souza Leite; Drissia Ferreira; Lucas Melo Matos; Sadi Antonio Pezzi Junior; Julia França Torres; Caren Cristine Oliveira Gomes; Amanda Roberta Fonsêca do Nascimento; Francisco Savio Machado Lima Gabriel; Dalila Sousa Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
